Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2009-06-02

FDA Approved: ULTRA SLEEP AID — Supplemental Application (Walgreen Company)

View source ↗

Summary

The FDA approved Walgreens' supplemental application for Ultra Sleep Aid (doxylamine succinate), indicating a labeling change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ULTRA SLEEP AID (Doxylamine succinate)

Snippet

SUPPL AP for ULTRA SLEEP AID (DOXYLAMINE SUCCINATE)